Entstehung und Prävention von Typ-1-Diabetes: die entscheidende Bedeutung der ersten Lebensjahre

Anette-Gabriele Ziegler

doi:10.1055/a-2384-6860

Diabetologie und Stoffwechsel, Table of Contents

Diabetologie und Stoffwechsel 2024; 19(05): 331-333
DOI: 10.1055/a-2384-6860

DDG-Preisträger

Entstehung und Prävention von Typ-1-Diabetes: die entscheidende Bedeutung der ersten Lebensjahre

Paul-Langerhans-Medaille 2024 – Kurzübersicht der Preisträgerin Anette-Gabriele Ziegler

Anette-Gabriele Ziegler

Abstract

Full Text

References

Literatur
1 Ziegler AG, Rewers M, Simell O. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013; 309: 2473-2479
2 Ziegler AG. The countdown to type 1 diabetes: when, how and why does the clock start?. Diabetologia 2023; 66: 1169-1178
3 Ziegler AG, Bonifacio E. BABYDIAB-BABYDIET Study Group. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012; 55: 1937-1943
4 Schenker M, Hummel M, Ferber K. et al. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia 1999; 42: 671-677
5 Ziegler AG, Danne T, Daniel C. et al. 100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention. Med (NY) 2021; 2: 1120-1137
6 Hoffmann VS, Weiss A, Winkler C. et al. Landmark models to define the age-adjusted risk of developing stage 1 type 1 diabetes across childhood and adolescence. BMC Med 2019; 17: 125
7 Assfalg R, Knoop J, Hoffman KL. et al. Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia 2021; 64: 1079-1092
8 Heninger AK, Eugster A, Kuehn D. et al. A divergent population of autoantigen-responsive CD4+ T cells in infants prior to β cell autoimmunity. Sci Transl Med 2017; 9: eaaf8848
9 Warncke K, Weiss A, Achenbach P. et al. Elevations in blood glucose before and after the appearance of islet autoantibodies in children. J Clin Invest 2022; 132: e162123
10 Vehik K, Lynch KF, Wong MC. et al. TEDDY Study Group. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med 2019; 25: 1865-1872
11 Zeller I, Weiss A, Arnolds S. et al. Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic. Infection 2024;
12 Weiss A, Donnachie E, Beyerlein A. et al. Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19. JAMA 2023; 329: 2089-2091
13 Lugar M, Eugster A, Achenbach P. et al. GPPAD Study Group. SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood. JAMA 2023; 330: 1151-1160
14 Friedl N, Sporreiter M, Winkler C. et al. Progression from pre-symptomatic to clinical type 1 diabetes after COVID-19 infection. JAMA 2024; 15: e2411174
15 Ziegler AG, Kick K, Bonicacio E. et al. Fr1da Study Group. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. JAMA 2020; 323: 339-351
16 Achenbach P, Berner R, Bonifacio E. et al. : Früherkennung von Typ-1-Diabetes durch Inselautoantikörper-Screening – ein Positionspapier der Fr1daPlex-Projektleiter und -Schulungszentren, des BVKJ Bayern und PaedNetz Bayern e.V. Gesundheitswesen 2024;
17 Hummel S, Carl J, Friedl N. et al. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia 2023; 66: 1633-1642